CK2β-regulated signaling controls B cell differentiation and function
L Quotti Tubi, E Mandato, S Canovas Nunes… - Frontiers in …, 2023 - frontiersin.org
Serine-Threonine kinase CK2 supports malignant B-lymphocyte growth but its role in B-cell
development and activation is largely unknown. Here, we describe the first B-cell specific …
development and activation is largely unknown. Here, we describe the first B-cell specific …
Protein kinase CK2: An emerging regulator of cellular metabolism
H Deng, X Rao, S Zhang, L Chen, Y Zong, R Zhou… - …, 2024 - Wiley Online Library
The protein kinase casein kinase 2 (CK2) exerts its influence on the metabolism of three
major cellular substances by phosphorylating essential protein molecules involved in …
major cellular substances by phosphorylating essential protein molecules involved in …
Decitabine‐Induced Changes in Human Myelodysplastic Syndrome Cell Line SKM‐1 Are Mediated by FOXO3A Activation
W Zeng, H Dai, M Yan, X Cai, H Luo… - Journal of immunology …, 2017 - Wiley Online Library
The epigenetic silencing of tumor suppressor genes in myelodysplastic syndromes (MDS)
can potentially confer a growth advantage to individual cellular clones. Currently, the …
can potentially confer a growth advantage to individual cellular clones. Currently, the …
Gene expression profiling unveils the temporal dynamics of CIGB-300-regulated transcriptome in AML cell lines
D Vázquez-Blomquist, AC Ramón, M Rosales… - BMC genomics, 2023 - Springer
Background Protein kinase CK2 activity is implicated in the pathogenesis of various
hematological malignancies like Acute Myeloid Leukemia (AML) that remains challenging …
hematological malignancies like Acute Myeloid Leukemia (AML) that remains challenging …
Phosphoproteomic landscape of AML cells treated with the ATP-competitive CK2 inhibitor CX-4945
Casein kinase 2 (CK2) regulates a plethora of proteins with pivotal roles in solid and
hematological neoplasia. Particularly, in acute myeloid leukemia (AML) CK2 has been …
hematological neoplasia. Particularly, in acute myeloid leukemia (AML) CK2 has been …
mechanistic basis for in vivo therapeutic efficacy of CK2 inhibitor CX-4945 in acute myeloid leukemia
Simple Summary Acute Myeloid Leukemia is an aggressive disease with poor outcomes.
New targeted therapies that can boost the effects of currently used chemotherapy …
New targeted therapies that can boost the effects of currently used chemotherapy …
Protein kinase CK2α is overexpressed in classical hodgkin lymphoma, regulates key signaling pathways, PD-L1 and may represent a new target for therapy
E Ruggeri, F Frezzato, N Mouawad, M Pizzi… - Frontiers in …, 2024 - frontiersin.org
Introduction In classical Hodgkin lymphoma (cHL), the survival of neoplastic cells is
mediated by the activation of NF-κB, JAK/STAT and PI3K/Akt signaling pathways. CK2 is a …
mediated by the activation of NF-κB, JAK/STAT and PI3K/Akt signaling pathways. CK2 is a …
Influence of Casein kinase II inhibitor CX-4945 on BCL6-mediated apoptotic signaling in B-ALL in vitro and in vivo
A Richter, S Sender, A Lenz, R Schwarz, B Hinz… - BMC cancer, 2020 - Springer
Abstract Background Casein kinase II (CK2) is involved in multiple tumor-relevant signaling
pathways affecting proliferation and apoptosis. CK2 is frequently upregulated in acute B …
pathways affecting proliferation and apoptosis. CK2 is frequently upregulated in acute B …
[HTML][HTML] Combination of solamargine and metformin strengthens IGFBP1 gene expression through inactivation of Stat3 and reciprocal interaction between FOXO3a …
Q Tang, F Zheng, JJ Wu, Q Xiao, L Li… - Cellular Physiology and …, 2017 - karger.com
Background/Aims: Solamargine, one natural photochemical component from traditional
plants, has been shown to have anti-cancers properties. We previously showed that …
plants, has been shown to have anti-cancers properties. We previously showed that …
Unexpected Binding Mode of a Potent Indeno[1,2-b]indole-Type Inhibitor of Protein Kinase CK2 Revealed by Complex Structures with the Catalytic Subunit CK2α and …
J Hochscherf, D Lindenblatt, B Witulski, R Birus… - Pharmaceuticals, 2017 - mdpi.com
Protein kinase CK2, a member of the eukaryotic protein kinase superfamily, is associated
with cancer and other human pathologies and thus an attractive drug target. The indeno [1, 2 …
with cancer and other human pathologies and thus an attractive drug target. The indeno [1, 2 …